Open for inclusion

Brentuxumab vedotin or B-CAP in treatment of older patients with newly diagnosed classical Hodgkin Lymphoma - a GHSG-NLG Intergroup Phase II- trial

Cancer type: Lymphoma

Phase: II

Principal Investigator: Leppä Sirpa

Country: FI

Keywords: Finland, Helsinki

Status: Open for inclusion